|
L15/TGF-beta trap fusokine for treatment of pediatric sarcomas |
The Board of Regents of the University of Wisconsin System |
Northwestern Mutual Foundation |
|
DEFINING GENETIC DRIVER MUTATIONS,CLINIC CHARACTERISTICS & OUTCOMES IN CHILDREN & YOUNG ADULTS WITH HISTIOCYTOSES |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Families of Children with Advanced Cancer: The Impact of Social Determinants of Health |
Research Institute at Nationwide Children's Hospital |
Northwestern Mutual Foundation |
|
Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants |
University of Washington, Seattle |
The RUNX1 Research Program |
|
Using Chemical Genetics to Define the Precise Role of RUNX1 in Transcription and Beyond |
Albert Einstein College of Medicine |
The RUNX1 Research Program |
|
Targeting the biological underpinnings of pulmonary metastasis in osteosarcoma |
Dana-Farber Cancer Institute |
Sammy’s Superheroes Foundation |
|
Understanding and inhibiting mechanisms of metastatic spread in osteosarcoma |
University of California San Francisco |
The Bryce Bazor Foundation |
|
Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Redefining Osteosarcoma Metastases as Chronic Non-healing Lung Wounds: Implications for Developing Novel Therapies |
Research Institute at Nationwide Children's Hospital |
Northwestern Mutual Foundation |
|
Activating Metabolic Pathways to Increase the Persistence of Leukemia Targeting T Cells |
Children’s Hospital of Pittsburgh |
Northwestern Mutual Foundation |
